Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-08-30

Clinical Trial Update: Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating appropriate inhaler use in COPD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: WITHDRAWN